GEO DataSet Links for SRA (Select 28988473) - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Links from SRA

Items: 2

Select item 3077448301.

R009

Organism:: Homo sapiens

Source name:: Metastatic Triple-Negative Breast Cancer PRE treatment

Platform:: GPL20301
Series:: GSE241876

Download data

Sample

Accession:: GSM7744830

ID:: 307744830

SRA Run Selector

Select item 2002418762.

Distinct Transcriptional Landscapes Identified by Radiographic Response in Metastatic Triple-Negative Breast Cancer Treated with Carboplatin, Nab-Paclitaxel, and Pembrolizumab in a Single-Arm Phase II Trial

(Submitter supplied) A single arm, Phase II trial of carboplatin, nab-paclitaxel, and pembrolizumab (CNP) in metastatic triple negative breast cancer (mTNBC) was designed to evaluate overall response rate (ORR), progression-free survival (PFS), duration of response (DOR), safety/tolerability, and identify pathologic and transcriptomic correlates of response to therapy.